EVIDENCE LIBRARY
Reporting Limits in Forensic Toxicology: LOD, LOQ & Low-Level Results
Forensic interpretation of LOD, LOQ/LLOQ, reporting limits, cutoffs, validation, and why a detected signal is not automatically a defensible quantitative result.
Quick answer: The limit of detection (LOD) is the lowest concentration at which an analytical method can reliably distinguish an analyte from background under defined conditions. The limit of quantitation (LOQ or LLOQ) is the lowest concentration at which the method can produce a quantitative result that meets its validated performance criteria. A result can therefore be detectable without being validly quantifiable. Neither concept should be confused with a laboratory reporting cutoff, a screening cutoff, or a legal threshold.
Why LOD and LOQ matter in forensic interpretation
Forensic toxicology reports often present apparently simple conclusions—positive, negative, detected, not detected, or a numerical concentration. Those conclusions depend on analytical boundaries established during method validation. Understanding those boundaries is essential when evaluating low-level findings, trace detections, negative results, confirmation results, and concentrations near the bottom of a calibration range.
The Scientific Working Group for Forensic Toxicology (SWGTOX) method-validation guidance treats both limit of detection and limit of quantitation as specific validation parameters, alongside calibration, bias, precision, carryover, interference, matrix effects, dilution integrity, and stability. The underlying purpose of validation is not merely to demonstrate that an instrument can produce a signal, but to establish objective evidence that the method performs adequately for its intended forensic use. See the SWGTOX Standard Practices for Method Validation in Forensic Toxicology.
LOD: the boundary for reliable detection
The LOD addresses a qualitative question: can the method reliably detect that the analyte is present above background? Laboratories may estimate or establish an LOD using different statistically and experimentally supported approaches. The exact procedure matters because an LOD is a property of a validated analytical method in a defined matrix and configuration—not a universal property of the drug itself.
An LOD can change when the specimen matrix changes, when extraction volume changes, when instrumentation changes, when chromatographic conditions change, or when identification criteria are revised. An LOD established for whole blood should not automatically be assumed to apply to urine, serum, plasma, vitreous humor, oral fluid, or a different extraction protocol.
LOQ or LLOQ: the boundary for defensible quantitation
The LOQ—often reported as the lower limit of quantitation or LLOQ—addresses a different question: at what lowest concentration can the laboratory report a number with validated quantitative performance? Quantitation ordinarily requires more than recognizable signal. The low-end calibrator and validation data must satisfy the laboratory’s criteria for properties such as bias, precision, identification, and calibration performance.
That distinction is practical. A chromatographic peak may be detectable below the validated quantitative range while still being unsuitable for reporting as a precise numerical concentration. Reporting an extrapolated number below the LLOQ can imply a degree of numerical reliability the validation did not establish.
LOD is not the same as a reporting cutoff
Analytical sensitivity and reporting policy are separate concepts. A laboratory may be capable of detecting a drug below the concentration it has chosen or is required to report. Screening cutoffs, confirmation cutoffs, administrative thresholds, workplace-testing cutoffs, and statutory thresholds can all sit above an instrument’s analytical detection capability.
For that reason, a report stating “negative” does not necessarily mean zero analyte was present. It may mean that the laboratory did not detect the analyte under the method used, that the analyte was below the reporting threshold, that the analyte was outside the assay’s target list, or that the specimen/method combination was not capable of answering the broader question being asked. See Toxicology Reporting Cutoffs: Screening, Confirmation & Interpretation and Qualitative vs Quantitative Toxicology.
Why a detected signal is not automatically a quantitative result
At very low concentrations, uncertainty can increase and analytical behavior can become less stable. Signal-to-noise characteristics, chromatographic integration, ion ratios, interferences, carryover, matrix effects, calibration weighting, and extraction recovery can become increasingly important. A defensible low-level quantitative result therefore depends on the validated method as a whole rather than on the mere presence of a peak.
This is why method review should ask not only whether a target ion or transition was observed, but also whether the result met the laboratory’s complete identification and quantitation criteria. For related concepts, see Method Validation in Forensic Toxicology, Analytical Selectivity, and Measurement Uncertainty in Forensic Toxicology. For close numerical boundaries, see Measurement Uncertainty Near Forensic Toxicology Cutoffs.
Matrix-specific limits matter
Forensic laboratories work with matrices that differ substantially in composition and analytical difficulty. Whole blood, plasma, urine, vitreous humor, oral fluid, and hair do not present equivalent extraction efficiency, background, matrix effects, or analyte distribution. A low LOD in one matrix does not establish the same sensitivity in another.
A contemporary example comes from a 2026 whole-blood cannabinoid LC-MS/MS method using 50 microliters of specimen. The authors reported compound-specific LODs and LLOQs rather than a single universal sensitivity value, illustrating that analytical limits are method-, analyte-, and matrix-dependent. See the Journal of Analytical Toxicology method-validation study.
Questions to ask when a result is near the low end
When a case turns on a trace or low-level result, the laboratory record should permit a reviewer to determine whether the signal is analytically defensible and whether sequence-specific artifacts were excluded. In LC-MS/MS casework, that includes reviewing carryover controls, injection order, and the specimens immediately preceding the questioned result.
A reviewer should then determine:
- What LOD and LLOQ were established for this analyte in this specimen matrix?
- How were the LOD and LLOQ established during validation?
- Was the reported concentration inside the validated calibration range?
- Did the result meet the laboratory’s identification criteria, including retention time and ion/transition criteria where applicable?
- What were the applicable reporting and confirmation cutoffs?
- Were blanks, controls, and calibrators acceptable in the analytical batch?
- Was carryover evaluated, particularly after high-concentration specimens?
- Were matrix effects, interferences, and dilution procedures validated for the method?
- Does the laboratory report results below the LLOQ qualitatively, suppress them, or use another defined policy?
LOD, LOQ, and impairment are different questions
Analytical detectability should not be confused with pharmacologic or behavioral significance. An assay may detect a drug at a very low concentration without that concentration establishing impairment, toxicity, time of use, dose, or causation. Those are interpretive questions requiring pharmacokinetic, pharmacodynamic, specimen, timing, and case-context evidence beyond the validation parameter itself.
Bottom line
LOD answers whether a method can reliably detect an analyte; LOQ/LLOQ answers whether the method can reliably assign a quantitative value at the low end of its validated range. Reporting cutoffs are separate policy or regulatory thresholds. In forensic review, those distinctions can determine whether a low-level finding supports a qualitative conclusion, a numerical concentration, or no defensible inference beyond the analytical observation itself.
Related forensic toxicology references
- Method Validation in Forensic Toxicology
- Qualitative vs Quantitative Toxicology
- Toxicology Reporting Cutoffs
- Measurement Uncertainty in Forensic Toxicology
- Analytical Selectivity
Scientific review and attribution: The Trillest: A Working Group of Forensic Toxicology and Pharmacology Experts from a Variety of Scientific Backgrounds & with a Variety of Opinions.